Evaluation of two-dimensional dose distributions for pre-treatment patient-specific IMRT dosimetry

被引:5
|
作者
Radojcic, Deni Smilovic [1 ]
Rajlic, David [1 ]
Casar, Bozidar [2 ]
Kolacio, Manda Svabic [1 ]
Obajdin, Nevena [1 ]
Faj, Dario [3 ,4 ]
Jurkovic, Slaven [1 ,5 ]
机构
[1] Univ Hosp Rijeka, Med Phys Dept, Kresimirova 42, Rijeka, Croatia
[2] Inst Oncol LJubljana, Dept Radiat Phys, Ljubljana, Slovenia
[3] Univ Osijek, Fac Med, Osijek, Croatia
[4] Univ Osijek, Fac Dent Med & Hlth, Osijek, Croatia
[5] Univ Rijeka, Dept Med Phys & Biophys, Fac Med, Rijeka, Croatia
关键词
IMRT; 2D dose verification; gamma method; anthropomorphic phantom; WATER; VERIFICATION; PHOTON; TISSUE; BEAMS; FILM;
D O I
10.2478/raon-2018-0019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. The accuracy of dose calculation is crucial for success of the radiotherapy treatment. One of the methods that represent the current standard for patient-specific dosimetry is the evaluation of dose distributions measured with an ionization chamber array inside a homogeneous phantom using gamma method. Nevertheless, this method does not replicate the realistic conditions present when a patient is undergoing therapy. Therefore, to more accurately evaluate the treatment planning system (TPS) capabilities, gamma passing rates were examined for beams of different complexity passing through inhomogeneous phantoms. Materials and methods. The research was performed using Siemens Oncor Expression linear accelerator, Siemens Somatom Open CT simulator and Elekta Monaco TPS. A 2D detector array was used to evaluate dose distribution accuracy in homogeneous, semi-anthropomorphic and anthropomorphic phantoms. Validation was based on gamma analysis with 3%/3mm and 2%/2mm criteria, respectively. Results. Passing rates of the complex dose distributions degrade depending on the thickness of non-water equivalent material. They also depend on dose reporting mode used. It is observed that the passing rate decreases with plan complexity. Comparison of the data for all set-ups of semi-anthropomorphic and anthropomorphic phantoms shows that passing rates are higher in the anthropomorphic phantom. Conclusions. Presented results raise a question of possible limits of dose distribution verification in assessment of plan delivery quality. Consequently, good results obtained using standard patient specific dosimetry methodology do not guarantee the accuracy of delivered dose distribution in real clinical cases.
引用
收藏
页码:346 / 352
页数:7
相关论文
共 50 条
  • [1] Gantry angle dependence in IMRT pre-treatment patient-specific quality controls
    Monti, Angelo Filippo
    Berlusconi, Chiara
    Gelosa, Stefania
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2013, 29 (02): : 204 - 207
  • [2] Dosimetry limitations and pre-treatment dose profile correction for sliding window IMRT
    Grigorov, G.
    Chow, J. C. L.
    Yazdani, N.
    IRANIAN JOURNAL OF RADIATION RESEARCH, 2010, 8 (02): : 61 - 74
  • [3] Evaluation of Dosimetry Check software for IMRT patient-specific quality assurance
    Narayanasamy, Ganesh
    Zalman, Travis
    Ha, Chul S.
    Papanikolaou, Niko
    Stathakis, Sotirios
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2015, 16 (03): : 329 - 338
  • [4] Comprehensive clinical evaluation of TomoEQA for patient-specific pre-treatment quality assurance in helical tomotherapy
    Kim, Changhwan
    Han, Min Cheol
    Lee, Young Kyu
    Shin, Han-Back
    Kim, Hojin
    Kim, Jin Sung
    RADIATION ONCOLOGY, 2022, 17 (01)
  • [5] Verification of patient-specific dose distributions in proton therapy using a commercial two-dimensional ion chamber array
    Arjomandy, Bijan
    Sahoo, Narayan
    Ciangaru, George
    Zhu, Ronald
    Song, Xiaofei
    Gillin, Michael
    MEDICAL PHYSICS, 2010, 37 (11) : 5831 - 5837
  • [6] EPID dosimetry - configuration and pre-treatment IMRT verification
    Grzadziel, Aleksandra
    Smolinska, Barbara
    Rutkowski, Roman
    Slosarek, Krzysztof
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2007, 12 (06) : 307 - 312
  • [7] EPID Dosimetry - Configuration and Pre-Treatment IMRT Verification
    Grzadziel, A.
    Smolinska, B.
    Rutkowski, R.
    Slosarek, K.
    WORLD CONGRESS ON MEDICAL PHYSICS AND BIOMEDICAL ENGINEERING 2006, VOL 14, PTS 1-6, 2007, 14 : 1932 - 1936
  • [8] Use of electronic portal imaging devices for pre-treatment and in vivo dosimetry patient-specific IMRT and VMAT QA: Report of AAPM Task Group 307
    Dogan, Nesrin
    Mijnheer, Ben. J.
    Padgett, Kyle
    Nalichowski, Adrian
    Wu, Chuan
    Nyflot, Matthew. J.
    Olch, Arthur. J.
    Papanikolaou, Niko
    Shi, Jie
    Holmes, Shannon. M.
    Moran, Jean
    Greer, Peter. B.
    MEDICAL PHYSICS, 2023, 50 (08) : E865 - E903
  • [9] Validation of a quick three-dimensional dose verification system for pre-treatment IMRT QA
    Nakaguchi Y.
    Araki F.
    Ono T.
    Tomiyama Y.
    Maruyama M.
    Nagasue N.
    Shimohigashi Y.
    Kai Y.
    Radiological Physics and Technology, 2015, 8 (1) : 73 - 80
  • [10] Clinical implementation of PerFRACTION™ for pre-treatment patient-specific quality assurance
    Kang, Sang-Won
    Lee, Boram
    Song, Changhoon
    Eeom, Keun-Yong
    Jang, Bum-Sup
    Kim, In Ah
    Kim, Jae-Sung
    Chung, Jin-Beom
    Kang, Seonghee
    Cho, Woong
    Shin, Dong-Suk
    Kim, Jin-Young
    Chun, Minsoo
    JOURNAL OF THE KOREAN PHYSICAL SOCIETY, 2022, 80 (06) : 516 - 525